Cargando…
Treatment Guidance for Patients With Lung Cancer During the Coronavirus 2019 Pandemic
The global coronavirus disease 2019 pandemic continues to escalate at a rapid pace inundating medical facilities and creating substantial challenges globally. The risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in patients with cancer seems to be higher, especially as...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Association for the Study of Lung Cancer. Published by Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227539/ https://www.ncbi.nlm.nih.gov/pubmed/32422364 http://dx.doi.org/10.1016/j.jtho.2020.05.001 |
_version_ | 1783534517685846016 |
---|---|
author | Dingemans, Anne-Marie C. Soo, Ross A. Jazieh, Abdul Rahman Rice, Shawn J. Kim, Young Tae Teo, Lynette L.S. Warren, Graham W. Xiao, Shu-Yuan Smit, Egbert F. Aerts, Joachim G. Yoon, Soon Ho Veronesi, Giulia De Cobelli, Francesco Ramalingam, Suresh S. Garassino, Marina C. Wynes, Murry W. Behera, Madhusmita Haanen, John Lu, Shun Peters, Solange Ahn, Myung-Ju Scagliotti, Giorgio V. Adjei, Alex A. Belani, Chandra P. |
author_facet | Dingemans, Anne-Marie C. Soo, Ross A. Jazieh, Abdul Rahman Rice, Shawn J. Kim, Young Tae Teo, Lynette L.S. Warren, Graham W. Xiao, Shu-Yuan Smit, Egbert F. Aerts, Joachim G. Yoon, Soon Ho Veronesi, Giulia De Cobelli, Francesco Ramalingam, Suresh S. Garassino, Marina C. Wynes, Murry W. Behera, Madhusmita Haanen, John Lu, Shun Peters, Solange Ahn, Myung-Ju Scagliotti, Giorgio V. Adjei, Alex A. Belani, Chandra P. |
author_sort | Dingemans, Anne-Marie C. |
collection | PubMed |
description | The global coronavirus disease 2019 pandemic continues to escalate at a rapid pace inundating medical facilities and creating substantial challenges globally. The risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in patients with cancer seems to be higher, especially as they are more likely to present with an immunocompromised condition, either from cancer itself or from the treatments they receive. A major consideration in the delivery of cancer care during the pandemic is to balance the risk of patient exposure and infection with the need to provide effective cancer treatment. Many aspects of the SARS-CoV-2 infection currently remain poorly characterized and even less is known about the course of infection in the context of a patient with cancer. As SARS-CoV-2 is highly contagious, the risk of infection directly affects the cancer patient being treated, other cancer patients in close proximity, and health care providers. Infection at any level for patients or providers can cause considerable disruption to even the most effective treatment plans. Lung cancer patients, especially those with reduced lung function and cardiopulmonary comorbidities are more likely to have increased risk and mortality from coronavirus disease 2019 as one of its common manifestations is as an acute respiratory illness. The purpose of this manuscript is to present a practical multidisciplinary and international overview to assist in treatment for lung cancer patients during this pandemic, with the caveat that evidence is lacking in many areas. It is expected that firmer recommendations can be developed as more evidence becomes available. |
format | Online Article Text |
id | pubmed-7227539 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | International Association for the Study of Lung Cancer. Published by Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-72275392020-05-18 Treatment Guidance for Patients With Lung Cancer During the Coronavirus 2019 Pandemic Dingemans, Anne-Marie C. Soo, Ross A. Jazieh, Abdul Rahman Rice, Shawn J. Kim, Young Tae Teo, Lynette L.S. Warren, Graham W. Xiao, Shu-Yuan Smit, Egbert F. Aerts, Joachim G. Yoon, Soon Ho Veronesi, Giulia De Cobelli, Francesco Ramalingam, Suresh S. Garassino, Marina C. Wynes, Murry W. Behera, Madhusmita Haanen, John Lu, Shun Peters, Solange Ahn, Myung-Ju Scagliotti, Giorgio V. Adjei, Alex A. Belani, Chandra P. J Thorac Oncol Review Article The global coronavirus disease 2019 pandemic continues to escalate at a rapid pace inundating medical facilities and creating substantial challenges globally. The risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in patients with cancer seems to be higher, especially as they are more likely to present with an immunocompromised condition, either from cancer itself or from the treatments they receive. A major consideration in the delivery of cancer care during the pandemic is to balance the risk of patient exposure and infection with the need to provide effective cancer treatment. Many aspects of the SARS-CoV-2 infection currently remain poorly characterized and even less is known about the course of infection in the context of a patient with cancer. As SARS-CoV-2 is highly contagious, the risk of infection directly affects the cancer patient being treated, other cancer patients in close proximity, and health care providers. Infection at any level for patients or providers can cause considerable disruption to even the most effective treatment plans. Lung cancer patients, especially those with reduced lung function and cardiopulmonary comorbidities are more likely to have increased risk and mortality from coronavirus disease 2019 as one of its common manifestations is as an acute respiratory illness. The purpose of this manuscript is to present a practical multidisciplinary and international overview to assist in treatment for lung cancer patients during this pandemic, with the caveat that evidence is lacking in many areas. It is expected that firmer recommendations can be developed as more evidence becomes available. International Association for the Study of Lung Cancer. Published by Elsevier Inc. 2020-07 2020-05-15 /pmc/articles/PMC7227539/ /pubmed/32422364 http://dx.doi.org/10.1016/j.jtho.2020.05.001 Text en © 2020 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Review Article Dingemans, Anne-Marie C. Soo, Ross A. Jazieh, Abdul Rahman Rice, Shawn J. Kim, Young Tae Teo, Lynette L.S. Warren, Graham W. Xiao, Shu-Yuan Smit, Egbert F. Aerts, Joachim G. Yoon, Soon Ho Veronesi, Giulia De Cobelli, Francesco Ramalingam, Suresh S. Garassino, Marina C. Wynes, Murry W. Behera, Madhusmita Haanen, John Lu, Shun Peters, Solange Ahn, Myung-Ju Scagliotti, Giorgio V. Adjei, Alex A. Belani, Chandra P. Treatment Guidance for Patients With Lung Cancer During the Coronavirus 2019 Pandemic |
title | Treatment Guidance for Patients With Lung Cancer During the Coronavirus 2019 Pandemic |
title_full | Treatment Guidance for Patients With Lung Cancer During the Coronavirus 2019 Pandemic |
title_fullStr | Treatment Guidance for Patients With Lung Cancer During the Coronavirus 2019 Pandemic |
title_full_unstemmed | Treatment Guidance for Patients With Lung Cancer During the Coronavirus 2019 Pandemic |
title_short | Treatment Guidance for Patients With Lung Cancer During the Coronavirus 2019 Pandemic |
title_sort | treatment guidance for patients with lung cancer during the coronavirus 2019 pandemic |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227539/ https://www.ncbi.nlm.nih.gov/pubmed/32422364 http://dx.doi.org/10.1016/j.jtho.2020.05.001 |
work_keys_str_mv | AT dingemansannemariec treatmentguidanceforpatientswithlungcancerduringthecoronavirus2019pandemic AT soorossa treatmentguidanceforpatientswithlungcancerduringthecoronavirus2019pandemic AT jaziehabdulrahman treatmentguidanceforpatientswithlungcancerduringthecoronavirus2019pandemic AT riceshawnj treatmentguidanceforpatientswithlungcancerduringthecoronavirus2019pandemic AT kimyoungtae treatmentguidanceforpatientswithlungcancerduringthecoronavirus2019pandemic AT teolynettels treatmentguidanceforpatientswithlungcancerduringthecoronavirus2019pandemic AT warrengrahamw treatmentguidanceforpatientswithlungcancerduringthecoronavirus2019pandemic AT xiaoshuyuan treatmentguidanceforpatientswithlungcancerduringthecoronavirus2019pandemic AT smitegbertf treatmentguidanceforpatientswithlungcancerduringthecoronavirus2019pandemic AT aertsjoachimg treatmentguidanceforpatientswithlungcancerduringthecoronavirus2019pandemic AT yoonsoonho treatmentguidanceforpatientswithlungcancerduringthecoronavirus2019pandemic AT veronesigiulia treatmentguidanceforpatientswithlungcancerduringthecoronavirus2019pandemic AT decobellifrancesco treatmentguidanceforpatientswithlungcancerduringthecoronavirus2019pandemic AT ramalingamsureshs treatmentguidanceforpatientswithlungcancerduringthecoronavirus2019pandemic AT garassinomarinac treatmentguidanceforpatientswithlungcancerduringthecoronavirus2019pandemic AT wynesmurryw treatmentguidanceforpatientswithlungcancerduringthecoronavirus2019pandemic AT beheramadhusmita treatmentguidanceforpatientswithlungcancerduringthecoronavirus2019pandemic AT haanenjohn treatmentguidanceforpatientswithlungcancerduringthecoronavirus2019pandemic AT lushun treatmentguidanceforpatientswithlungcancerduringthecoronavirus2019pandemic AT peterssolange treatmentguidanceforpatientswithlungcancerduringthecoronavirus2019pandemic AT ahnmyungju treatmentguidanceforpatientswithlungcancerduringthecoronavirus2019pandemic AT scagliottigiorgiov treatmentguidanceforpatientswithlungcancerduringthecoronavirus2019pandemic AT adjeialexa treatmentguidanceforpatientswithlungcancerduringthecoronavirus2019pandemic AT belanichandrap treatmentguidanceforpatientswithlungcancerduringthecoronavirus2019pandemic |